Form 4 for AGNT AGNT, Inc.
Accepted 2022-03-09 00:00:00 ET · period of report 2022-03-07 · accession 0001562180-22-002476 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-03-09 | 2022-03-07+ | AGNT | Onnen Stacey | Pres, U.S. Brokerage Ops | M - OptEx | $5.04 | +50.0K | 11.2K | New | +$251.8K |
| DM | 2022-03-09 | 2022-03-07+ | AGNT | Onnen Stacey | Pres, U.S. Brokerage Ops | S - Sale+OE | $23.41 | -50.0K | 410 | -99% | -$1.17M |
| DM | 2022-03-09 | 2022-03-07+ | AGNT | Onnen Stacey | Pres, U.S. Brokerage Ops | M - OptEx | $0.00 | -50.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-07 | M | A | 9,911 | $4.58 | 10,321 | D | — | — | |
| 2 | Common | Common Stock | 2022-03-07 | M | A | 12,500 | $6.40 | 22,821 | D | — | — | |
| 3 | Common | Common Stock | 2022-03-07 | S | D | 22,411 | $23.28 | 410 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.82, inclusive. The reporting person undertakes to provide to EXP World Holdings, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. |
| 4 | Common | Common Stock | 2022-03-08 | M | A | 16,784 | $4.58 | 17,194 | D | — | — | |
| 5 | Common | Common Stock | 2022-03-08 | S | D | 16,784 | $23.26 | 410 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.74, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. |
| 6 | Common | Common Stock | 2022-03-09 | M | A | 10,805 | $4.58 | 11,215 | D | — | — | |
| 7 | Common | Common Stock | 2022-03-09 | S | D | 10,505 | $23.89 | 710 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.405 to $24.35, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. |
| 8 | Common | Common Stock | 2022-03-09 | S | D | 300 | $24.43 | 410 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.43 to $24.44, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. |
| 9 | Derivative | Stock Option (Right to Buy) | 2022-03-08 | M | D | 16,784 | $0.00 | 10,805 | D | $4.58 · — to 2030-03-06 | 16,784 Common Stock | (F6) This Stock Option vests in 16 equal quarterly installments beginning on March 7, 2020. |
| 10 | Derivative | Stock Option (Right to Buy) | 2022-03-07 | M | D | 9,911 | $0.00 | 27,589 | D | $4.58 · — to 2030-03-06 | 9,911 Common Stock | (F6) This Stock Option vests in 16 equal quarterly installments beginning on March 7, 2020. |
| 11 | Derivative | Stock Option (Right to Buy) | 2022-03-07 | M | D | 12,500 | $0.00 | 0 | D | $6.40 · — to 2028-02-29 | 12,500 Common Stock | (F5) The option grant is fully vested. |
| 12 | Derivative | Stock Option (Right to Buy) | 2022-03-09 | M | D | 10,805 | $0.00 | 0 | D | $4.58 · — to 2030-03-06 | 10,805 Common Stock | (F6) This Stock Option vests in 16 equal quarterly installments beginning on March 7, 2020. |